Immune-mediated comorbidities in Saudi patients with narcolepsy
Majed Alomar,1 Aljohara S Almeneessier,1,2 Awad H Olaish,1 Abdulrahman Alshiban,1 Abdullah Alomar,1 Ahmed S BaHammam1,31The University Sleep Disorders Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Family and Community Medicine Department, College o...
Enregistré dans:
| Auteurs principaux: | Alomar M, Almeneessier AS, Olaish AH, Alshiban A, Alomar A, BaHammam AS |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/55b1420d05e744bd879797f19b24a3a8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns
par: Barker EC, et autres
Publié: (2020) -
Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHAD
par: Wang YG, et autres
Publié: (2017) -
Orgasmolepsy in Narcolepsy Type 1 Responsive to Pitolisant: A Case Report
par: Pellitteri G, et autres
Publié: (2020) -
Treatment paradigms for cataplexy in narcolepsy: past, present, and future
par: Swick TJ
Publié: (2015) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
par: Vellieux G, et autres
Publié: (2021)